Methods for the treatment and prevention of APP processing disorders such as Alzheimer's disease and Down's Syndrome which are based on the administration of an effective amount of a HMG-CoA reductase inhibitor to a mammal are disclosed. Additionally, methods for treatment and prevention of APP processing disorders such as Alzheimer's disease and Down's Syndrome which are based on the reduction of cellular cholesterol in a mammal are disclosed. These methods reduce the amount of AB peptides or decrease the formation of AB peptides or increase the clearance of AB peptides in a mammal suffering from Alzheimer's disease and Down's Syndrome. Figure (1) is a schematic which illustrates APP processing.
申请公布号
WO02062824(A3)
申请公布日期
2002.11.21
申请号
WO2002US03256
申请日期
2002.02.05
申请人
ANDRX CORPORATION;FRIEDHOFF, LAWRENCE;BUXBAUM, JOSEPH;CULLEN, EDWARD, I.
发明人
FRIEDHOFF, LAWRENCE;BUXBAUM, JOSEPH;CULLEN, EDWARD, I.